array(1) { [0]=> object(Apache_Solr_Document)#24 (3) { ["_documentBoost":protected]=> bool(false) ["_fields":protected]=> array(6) { ["content_id"]=> array(1) { [0]=> string(14) "DIRECTORY_3142" } ["content_title"]=> array(1) { [0]=> string(14) "CARMINE STOLFI" } ["description"]=> array(1) { [0]=> string(11953) "

STOLFI Carmine

 

Dati personali:

Luogo e data di nascita: Roma (RM), 2 Febbraio 1977

Nazionalità: Italiana

Indirizzo di lavoro: Dipartimento di Medicina dei Sistemi, Università degli Studi di Roma “Tor Vergata”, Via Montpellier, 1, 00133, Roma (RM)

Telefono: 06-72596411

E mail: carmine.stolfi@uniroma2.it

 

Posizione attuale:

RTD-B, Dipartimento di Medicina dei Sistemi, Università degli Studi di Roma “Tor Vergata”, Roma.

Titoli di studio:

02/2010   Dottorato di ricerca in “Fisiopatologia Sperimentale” presso l’Università degli Studi di Roma “Tor Vergata”.

03/2004   Laurea in Scienze Biologiche, Università degli Studi di Roma “La Sapienza”

 

Posizioni accademiche:

11/2023 – ad oggi   RTD-B, Dipartimento di Medicina dei Sistemi, Università degli Studi di Roma “Tor Vergata”.

07/2020 – 07/2023   RTD-A, Dipartimento di Medicina dei Sistemi, Università degli Studi di Roma “Tor Vergata”.

09/2016 – 07/2020   Ricercatore Principale, Dipartimento di Medicina dei Sistemi, Università degli Studi di Roma “Tor Vergata”.

09/2014 – 7/2016   Ricercatore Post-Doc, Dipartimento di Medicina Interna, Università del Michigan, Ann Arbor, MI, U.S.A.

03/2010 – 08/2014   Ricercatore Post-Doc, Dipartimento di Medicina dei Sistemi, Università degli Studi di Roma “Tor Vergata”.

 

Responsabilità scientifica di progetti di ricerca

10/2023 – 10/2025   BANDO PRIN 2022: Titolo del Progetto di Ricerca: Role of Smad7 in the regulation of extracellular adenosine triphosphate (eATP)-mediated oncogenic pathways and tumor immunity in colorectal cancer (CRC).

04/2022 – 04/2024   Università di Roma “Tor Vergata”, Dipartimento di medicina dei Sistemi: Finanziamento per progetti di ricerca competitivi per lo sviluppo di idee ad alto contenuto scientifico e tecnologico con progetto intitolato “Multifunctional DNA nanostructures for targeted therapy of colorectal cancer”.

01/2012 – 12/2024   Associazione Italiana per la Ricerca sul Cancro: My First A.I.R.C. Grant (MFAG) 2011 con il progetto dal titolo: “Role of Interleukin-21 in the growth of colorectal cancer”.

 

 

Premi

2024   Biomedicines 2022 Best Paper Award per la review “Implication of intestinal epithelial barrier dysfunction in gut dysbiosis”, Carmine Stolfi*, Claudia Maresca, Giovanni Monteleone, Federica Laudisi*. Biomedicines. 2022 Jan 27;10(2):289. doi: 10.3390/biomedicines10020289.

2011   Premio di ricerca della Società Italiana di Gastroenterologia (SIGE)

 

Esperto valutatore per le seguenti associazioni nella selezione di progetti internazionali

FCT — Fundação para a Ciência e a Tecnologia (Portugal), Rosetrees Trust (UK), FWO — Fonds voor Wetenschappelijk Onderzoek (Belgium), European Union’s Horizon 2020 Research and Innovation Programme — AIAS-COFUND Marie Skłodowska-Curie Fellowships, Modernizing Uzbekistan’s National Innovation System (Munis) – Business Investment in R&D Programme (BIRD), Fonds National de la Recherche (FNR) Luxembourg

Attività di referee per le seguenti riviste internazionali

Gastroenterology, Gut, Cancer Research, Oncogene, Journal for ImmunoTherapy of Cancer, International Journal of Cancer, Oncoimmunology, Molecular Oncology, The FASEB Journal, Medicinal Research Reviews, The Journal of Pathology, Inflammatory Bowel Diseases, Angiogenesis, European Journal of Pharmacology, International Journal of Molecular Sciences, Scientific Reports.

Attività didattica

dal 2024   Docente titolare dell’ insegnamento di Research Methodology, nell’ambito del Corso di Laurea Magistrale in inglese “Physical Activity and Health Promotion”, presso la Facoltà di Medicina e Chirurgia dell’Università degli Studi di Roma “Tor Vergata”.

dal 2024 Docente titolare dell’insegnamento di Immunotecnologia (nel corso integrato di Biotecnologie Molecolari e Cellulari) nell’ambito del Corso di Laurea Magistrale in Biotecnologie Mediche presso la Facoltà di Medicina e Chirurgia dell’Università degli Studi di Roma “Tor Vergata”.

Attività di supervisione e coordinamento di un progetto di Tesi di Laurea nell’ambito del Corso di Laurea in “Chimica e Tecnologie Farmaceutiche” presso l’Università degli Studi di Roma “La Sapienza” e di diversi progetti di Tesi di Laurea nell’ambito dei Corsi di Laurea in “Biotecnologie Mediche”, “Biologia ed Evoluzione Umana”, e di “Medicina e Chirurgia” presso l’Università degli Studi di Roma “Tor Vergata”

Attività di supervisione e coordinamento di diversi progetti di Dottorato di Ricerca in “Fisiopatologia Sperimentale” presso la Facoltà di Medicina e Chirurgia dell’Università degli Studi di Roma “Tor Vergata”.

Pubblicazioni

Autore di 97 pubblicazioni su riviste internazionali con revisione tra pari, di cui 22 come “first author”, 20 come “senior author”, e 24 come “corresponding author”. H-index: 39.

STOLFI Carmine

 

Personal data:

Place and date of birth: Rome (RM), 2 February 1977

Italian nationality

Work address: Department of Systems Medicine, University of Rome “Tor Vergata”, Via Montpellier, 1, 00133, Rome (RM)

Telephone: 06-72596411

Email:carmine.stolfi@uniroma2.it

 

Actual position:

Assistant professor (RTD-B), Department of Systems Medicine, University of Rome “Tor Vergata”, Rome.

 

Qualifications:

National Scientific Qualification (2018/2020 call) for the role of Second Level Professor in the competitive sector 05/E3 “Clinical biochemistry and clinical molecular biology” with validity of the qualification from 04/20/2021 to 04/20/2032.

National Scientific Qualification (2016 call) for the role of Second Level Professor in the competition sector 06/N1 with validity of the qualification from 31/03/2017 to 31/03/2028.

National Scientific Qualification (2016 call) for the role of Second Level Professor in the competitive sector 06/A2 with validity of the qualification from 03/28/2017 to 03/28/2028.

National Scientific Qualification (2016 call) for the role of Second Level Professor in the competitive sector 06/D4 with validity of the qualification from 10/04/2017 to 10/04/2028.

02/2010 PhD in “Experimental Physiopathology” at the University of Rome “Tor Vergata”.

03/2004 Degree in Biological Sciences, University of Rome “La Sapienza”

 

Academic positions:

11/2023 – to date RTD-B, Department of Systems Medicine, University of Rome “Tor Vergata”.

07/2020 – 07/2023 RTD-A, Department of Systems Medicine, University of Rome “Tor Vergata”.

09/2016 – 07/2020 Principal Researcher, Department of Systems Medicine, University of Rome “Tor Vergata”.

09/2014 – 7/2016 Post-Doc Researcher, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA

03/2010 – 08/2014 Post-Doc Researcher, Department of Systems Medicine, University of Rome “Tor Vergata”.

 

Scientific responsibility for research projects

10/2023 – 10/2025  Research projects of national interest (PRIN) 2022: Title of the Research Project: Role of Smad7 in the regulation of extracellular adenosine triphosphate (eATP)-mediated oncogenic pathways and tumor immunity in colorectal cancer (CRC).

04/2022 – 04/2024  University of Rome “Tor Vergata”, Department of Systems Medicine: Funding for competitive research projects for the development of ideas with high scientific and technological content with a project entitled “Multifunctional DNA nanostructures for targeted therapy of colorectal cancer”.

01/2012 – 12/2024  Italian Association for Cancer Research: My First AIRC Grant (MFAG) 2011 with the project entitled: “Role of Interleukin-21 in the growth of colorectal cancer”.

Prizes

2024   Biomedicines 2022 Best Paper Award for the review “Implication of intestinal epithelial barrier dysfunction in gut dysbiosis”, Carmine Stolfi*, Claudia Maresca, Giovanni Monteleone, Federica Laudisi*. Biomedicines. 2022 Jan 27;10(2):289. doi: 10.3390/biomedicines10020289.

2011  Research Award of the Italian Society of Gastroenterology (SIGE)

 

Expert evaluator for the following associations in the selection of international projects

FCT — Fundação para a Ciência ea Tecnologia (Portugal), Rosetrees Trust (UK), FWO — Fonds voor Wetenschappelijk Onderzoek (Belgium), European Union's Horizon 2020 Research and Innovation Program — AIAS-COFUND Marie Skłodowska-Curie Fellowships, Modernizing Uzbekistan's National Innovation System (Munis) – Business Investment in R&D Program (BIRD), Fonds National de la Recherche (FNR) Luxembourg

Referee activity for the following international journals

Gastroenterology, Gut, Cancer Research, Oncogene, Journal for ImmunoTherapy of Cancer, International Journal of Cancer, Oncoimmunology, Molecular Oncology, The FASEB Journal, Medicinal Research Reviews, The Journal of Pathology, Inflammatory Bowel Diseases, Angiogenesis, European Journal of Pharmacology, International Journal of Molecular Sciences, Scientific Reports.

Teaching activity

Since 2024 Professor of Research Methodology, as part of the Master's Degree Course in English "Physical Activity and Health Promotion", at the Faculty of Medicine and Surgery of the University of Rome "Tor Vergata".

Since 2024 Professor of Immunotechnology (in the integrated course of Molecular and Cellular Biotechnology) as part of the Master's Degree Course in Medical Biotechnology at the Faculty of Medicine and Surgery of the University of Rome “Tor Vergata”.

Supervision and coordination of a degree thesis project within the degree course in "Pharmaceutical Chemistry and Technologies" at the University of Rome "La Sapienza" and of various degree thesis projects within the Degree courses in "Medical Biotechnology", "Biology and Human Evolution", and "Medicine and Surgery" at the University of Rome "Tor Vergata"

Supervision and coordination of various PhD projects in "Experimental Physiopathology" at the Faculty of Medicine and Surgery of the University of Rome "Tor Vergata".

Publications

Author of 97 publications in international peer-reviewed journals, of which 22 as “first author”, 20 as “senior author”, and 24 as “corresponding author”. H-index: 39.

 a:0:{}" } ["meta_keywords"]=> array(1) { [0]=> string(1) "," } ["reserved"]=> array(1) { [0]=> string(1) "0" } ["auth_ip"]=> array(1) { [0]=> string(1) "0" } } ["_fieldBoosts":protected]=> array(6) { ["content_id"]=> bool(false) ["content_title"]=> bool(false) ["description"]=> bool(false) ["meta_keywords"]=> bool(false) ["reserved"]=> bool(false) ["auth_ip"]=> bool(false) } } }